Sign in →

Order Code CLD18 Claudin 18 (CLDN18) (43-14A), Semi-Quantitative Immunohistochemistry, Manual


Shipping Instructions


Attach the green "Attention Pathology" address label (T498) to the outside of the transport container before putting into the courier mailer.



Necessary Information


A pathology/diagnostic report and a brief history are required.



Specimen Required


This assay requires at least 50 tumor cells.

 

Specimen Type: Tissue

Supplies: Pathology Packaging Kit (T554)

Submit:

Formalin-fixed, paraffin-embedded tissue block

OR

3 unstained glass, "positively charged" slides with 4-microns formalin-fixed, paraffin-embedded tissue

Additional Information: One slide will be stained with hematoxylin and eosin and returned.


Useful For

Identification of tumor cells expressing claudin 18

 

As an aid in screening patients who may be eligible for VYLOY (zolbetuximab) treatment

Method Name

Immunohistochemistry (IHC)

Reporting Name

CLDN18, SemiQuant IHC, Manual

Specimen Type

Special

Specimen Stability Information

Specimen Type Temperature Time
Special Ambient (preferred)
  Refrigerated 

Reject Due To

Decalcified paraffin embedded tissue Reject
Wet/frozen tissue Reject
Cytology smears Reject
Nonformalin fixed tissue including alcohol-formalin-acetic acid (AFA), 95% ethanol, PREFER fixatives or Zinc formalin Reject
Nonparaffin embedded tissue Reject
Noncharged slides Reject
ProbeOn slides Reject

Reference Values

An interpretive report will be provided.

Method Description

Immunoperoxidase staining and detection of Claudin 18 (CLDN18) is performed in formalin-fixed, paraffin-embedded tissue sections using the VENTANA CLDN18 (43-14A) RxDx Assay. The 4-micron tissue sections are deparaffinized, subjected to heat-induced antigen retrieval and peroxidase inhibitor, incubated with a monoclonal antibody (clone 43-14A), and visualized using a proprietary kit detection system. Sections are counterstained with hematoxylin. Stained slides are examined microscopically by the consulting anatomic pathologist.(Package insert: VENTANA CLDN18 (43-14A) RxDx Assay. Ventana Medical Systems, Inc.; 1016387US Rev A, 10/11/2024)

 

Results are interpreted using the manufacturer-provided interpretation guide. A minimum of 50 tumor cells are required for interpretation of results.(Instruction manual: VENTANA CLDN18 (43-14A) RxDx Assay Interpretation Guide for Gastric Adenocarcinoma including Gastroesophageal Junction (GEJ). Ventana Medical Systems, Inc.; 1021576EN Rev B, 10/01/2024)

Day(s) Performed

Monday through Friday

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

88360

LOINC Code Information

Test ID Test Order Name Order LOINC Value
CLD18 CLDN18, SemiQuant IHC, Manual 105011-1

 

Result ID Test Result Name Result LOINC Value
620666 Interpretation 50595-8
621004 Participated in the Interpretation No LOINC Needed
621005 Report electronically signed by 19139-5
621006 Material Received 81178-6
621007 Disclaimer 62364-5
621008 Case Number 80398-1

Forms

If not ordering electronically, complete, print, and send a Immunohistochemical (IHC)/In Situ Hybridization (ISH) Stains Request (T763) with the specimen.